triclofos has been researched along with Hearing Loss in 1 studies
triclofos: derivative 7 metabolic precursor of trichloroethanol; RN given refers to parent cpd; structure
Hearing Loss: A general term for the complete or partial loss of the ability to hear from one or both ears.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oral triclofos was used for the sedation of younger patients (3-24 months) and intravenous propofol for older patients (>24 months)." | 1.48 | Frequency-specific auditory brainstem response testing with age-appropriate sedation. ( Levit, Y; Mandel, D; Matot, I, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Levit, Y | 1 |
| Mandel, D | 1 |
| Matot, I | 1 |
1 other study available for triclofos and Hearing Loss
| Article | Year |
|---|---|
Frequency-specific auditory brainstem response testing with age-appropriate sedation.
Topics: Auditory Threshold; Child; Child, Preschool; Deep Sedation; Evoked Potentials, Auditory, Brain Stem; | 2018 |